Posted by Michael Wonder on 04 Nov 2023
How should the FDA evaluate psychedelic medicine?
4 November 2023 - Drug companies are spending millions of dollars to incorporate psychedelic agents into health care. Working with research institutions, patient organisations, and veterans groups, they have gained bipartisan support in Congress.
Meanwhile, mounting clinical evidence is paving the way for the likely approval of new psychedelic medicines by the FDA.
